The Korean guideline for cervical cancer screening

scientific article published in July 2015

The Korean guideline for cervical cancer screening is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.3802/JGO.2015.26.3.232
P932PMC publication ID4510341
P698PubMed publication ID26197860

P50authorSoo Young KimQ38324747
Moran KiQ39498825
Jae-Weon KimQ40344066
Kyung-Jin MinQ41292180
Myong Cheol LimQ42931398
Chong Woo YooQ60686463
Yoon Jae LeeQ60686474
Jaekyung ChoiQ60686492
Mina SuhQ85638618
Yong Man KimQ85638621
Jea Hoon KimQ85638623
Eal Whan ParkQ85638624
Hoo Yeon LeeQ85638626
Sung Chul LimQ85638628
Chi Heum ChoQ85638630
Sung Ran HongQ85638631
Ji Yeon DangQ85638634
Yeol KimQ85638637
Won Chul LeeQ85638638
Jae Kwan LeeQ85638641
P2093author name stringMina Suh
Yeol Kim
Yong Man Kim
Jae Weon Kim
Sung Ran Hong
Won Chul Lee
Sung Chul Lim
Jae Kwan Lee
Hoo Yeon Lee
Chi Heum Cho
Ji Yeon Dang
Eal Whan Park
Kyung Jin Min
Jea Hoon Kim
P2860cites workAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerQ24607403
Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trialQ24679201
Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screeningQ24684588
Recommendations on screening for cervical cancerQ28282866
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tablesQ29547885
Cervical screening: a guideline for clinical practice in OntarioQ34255316
Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statementQ34282601
ACOG Practice Bulletin Number 131: Screening for cervical cancerQ34307625
AGREE II: advancing guideline development, reporting and evaluation in health careQ34403979
Human papillomavirus and Papanicolaou tests to screen for cervical cancerQ34702284
Papanicolaou test utilization and frequency of screening opportunities among women diagnosed with cervical cancerQ34954441
HPV screening for cervical cancer in rural IndiaQ34973414
Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 editionQ36817519
AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviewsQ37397185
Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trialQ37622656
The Japanese guideline for cervical cancer screeningQ37740813
Efficacy of screening in preventing invasive cervical cancer: a case-control study in Milan, ItalyQ39303191
Does screening by "Pap" smears help prevent cervical cancer? A case-control studyQ39551040
Evaluation of the cervical cancer screening programme in Mexico: a population-based case-control studyQ43460724
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.Q44320222
Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validityQ44948737
Direct comparison of liquid-based and conventional cytology in a South African screening trialQ46259100
Limited Pap screening associated with reduced risk of cervical cancer in South AfricaQ46928970
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.Q51824401
Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study.Q53530187
Screening for cervical cancer in Latin America: a case-control studyQ67509128
The impact of vaginal cytology on cervical cancer risks in Cali, ColombiaQ71429583
Relation between the incidence of invasive cervical cancer and the screening interval: is a five year interval too long?Q71839995
Evaluation of the effectiveness of cervical cancer screening: a case-control study in Miyagi, JapanQ72339056
Has the use of pap smears reduced the risk of invasive cervical cancer in Guadalajara, Mexico?Q78123222
Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control studyQ78132542
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialQ81404025
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trialQ82586477
Cervical cancer screeningQ82835733
P433issue3
P921main subjectcervix uterine cancerQ160105
P304page(s)232-239
P577publication date2015-07-01
P1433published inJournal of gynecologic oncologyQ26842232
P1476titleThe Korean guideline for cervical cancer screening
P478volume26

Reverse relations

cites work (P2860)
Q47669855A qualitative study exploring factors associated with Pap test use among North Korean refugees.
Q90865025Analytical performance evaluation of the HPV OncoCheck assay for detection of high-risk HPV infection in liquid-based cervical samples
Q36109828Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
Q49486128Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation.
Q39293151Cervical Cancer Screening and Its Associated Factors Among North Korean Defectors Living in South Korea
Q55024699Clinical and health policy experiences with HPV prevalence within the Hungarian organized cervical cancer screening program.
Q50073530Comparative evaluation of the Omniplex-HPV and RFMP HPV PapilloTyper for detecting human papillomavirus genotypes in cervical specimens
Q33729706Comparison of Unsatisfactory Samples from Conventional Smear versus Liquid-Based Cytology in Uterine Cervical Cancer Screening Test
Q57213824Comparison of cervical cancer screening among women with and without hysterectomies: a nationwide population-based study in Korea
Q47151440Current Cytology Practices in Korea: A Nationwide Survey by the Korean Society for Cytopathology.
Q92043900Current Status of and Perspectives on Cervical Cancer Screening in Korea
Q91592321High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
Q48107227Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy: a meta-analysis.
Q39313435Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years
Q38705377Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009-2014.
Q42373477Overview on Patient Centricity in Cancer Care
Q52960901Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
Q47110234Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Q55398396Proposal for cervical cancer screening in the era of HPV vaccination.
Q33760521Stratification of risk groups according to survival after recurrence in endometrial cancer patients
Q36008098The health beliefs of mothers about preventing cervical cancer and their intention to recommend the Pap test to their daughters: a cross-sectional survey

Search more.